Chunk #27 — OBSERVATIONS — Treatment: — Non-FDA-Approved Medications for Treating Alcohol Use Disorder (Table 2)

Source

Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.

Embedded

yes

Text

The adverse events reported most commonly with nalmefene (vs. placebo) were nausea (22.1% vs. 5.9%), dizziness (18.2% vs. 5.0%), insomnia (13.4% vs. 5.4%), headache (12.3% vs. 8.3%), vomiting (8.7% vs. 2.3%), fatigue (8.3% vs. 4.6%), and somnolence (5.2% vs. 2.9%).21